PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-175.33%
Negative net income growth while CRON.TO stands at 75.61%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
58.54%
Some D&A expansion while CRON.TO is negative at -56.49%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-604.67%
Negative yoy deferred tax while CRON.TO stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
116.21%
SBC growth well above CRON.TO's 52.31%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-110.50%
Both reduce yoy usage, with CRON.TO at -18.73%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-42.57%
AR is negative yoy while CRON.TO is 52.40%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
124.76%
Some inventory rise while CRON.TO is negative at -39.60%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-164.55%
Both negative yoy AP, with CRON.TO at -102.04%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
70.64%
Growth well above CRON.TO's 70.70%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-51.87%
Both negative yoy, with CRON.TO at -98.23%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-1622.35%
Negative yoy CFO while CRON.TO is 5.64%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-178.71%
Both yoy lines negative, with CRON.TO at -29.45%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-100.00%
Negative yoy acquisition while CRON.TO stands at 159.46%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-100.00%
Both yoy lines negative, with CRON.TO at -100.00%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-100.00%
Both yoy lines are negative, with CRON.TO at -99.93%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
336.42%
We have some outflow growth while CRON.TO is negative at -65.15%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-102.53%
Both yoy lines negative, with CRON.TO at -99.88%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
85.58%
Debt repayment growth of 85.58% while CRON.TO is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-100.00%
Both yoy lines negative, with CRON.TO at -100.00%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
No Data
No Data available this quarter, please select a different quarter.